These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 2941262)
21. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis. Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326 [TBL] [Abstract][Full Text] [Related]
22. Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers. Gonzalez MA; Moranchel AH; Duran S; Pichardo A; Magana JL; Painter B; Forrest A; Drusano GL Antimicrob Agents Chemother; 1985 Aug; 28(2):235-9. PubMed ID: 2939794 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses. Bergan T; Thorsteinsson SB; Kolstad IM; Johnsen S Eur J Clin Microbiol; 1986 Apr; 5(2):187-92. PubMed ID: 2941278 [TBL] [Abstract][Full Text] [Related]
24. Tissue penetration of ciprofloxacin after single and multiple doses. LeBel M; Vallée F; Bergeron MG Antimicrob Agents Chemother; 1986 Mar; 29(3):501-5. PubMed ID: 2940974 [TBL] [Abstract][Full Text] [Related]
25. Ciprofloxacin pharmacokinetics in patients with cystic fibrosis. Bender SW; Dalhoff A; Shah PM; Strehl R; Posselt HG Infection; 1986; 14(1):17-21. PubMed ID: 2937737 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Borner K; Höffken G; Lode H; Koeppe P; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reinitz D Eur J Clin Microbiol; 1986 Apr; 5(2):179-86. PubMed ID: 2941277 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients. Ball AP; Fox C; Ball ME; Brown IR; Willis JV J Antimicrob Chemother; 1986 May; 17(5):629-35. PubMed ID: 2941402 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of three oral formulations of ciprofloxacin. Davis RL; Koup JR; Williams-Warren J; Weber A; Smith AL Antimicrob Agents Chemother; 1985 Jul; 28(1):74-7. PubMed ID: 2931047 [TBL] [Abstract][Full Text] [Related]
31. Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin. Ledergerber B; Bettex JD; Joos B; Flepp M; Lüthy R Antimicrob Agents Chemother; 1985 Mar; 27(3):350-2. PubMed ID: 3158273 [TBL] [Abstract][Full Text] [Related]
32. Concentration of ciprofloxacin in human prostatic tissue after oral administration. Dan M; Golomb J; Gorea A; Braf Z; Berger SA Antimicrob Agents Chemother; 1986 Jul; 30(1):88-9. PubMed ID: 2944481 [TBL] [Abstract][Full Text] [Related]
33. Single and multiple dose pharmacokinetics of ciprofloxacin. Ullmann U; Giebel W; Dalhoff A; Koeppe P Eur J Clin Microbiol; 1986 Apr; 5(2):193-6. PubMed ID: 2941279 [TBL] [Abstract][Full Text] [Related]
34. Ciprofloxacin distribution in prostatic tissue and fluid following oral administration. Boerema JB; Dalhoff A; Debruyne FM Chemotherapy; 1985; 31(1):13-8. PubMed ID: 3156024 [TBL] [Abstract][Full Text] [Related]
35. Multiple-dose ciprofloxacin kinetics in normal subjects. Aronoff GE; Kenner CH; Sloan RS; Pottratz ST Clin Pharmacol Ther; 1984 Sep; 36(3):384-8. PubMed ID: 6467798 [TBL] [Abstract][Full Text] [Related]
37. Oral treatment of Pseudomonas-induced urinary tract infections with ciprofloxacin. Van Poppel H; Wegge M; Dammekens H; Chysky V Chemotherapy; 1986; 32(1):83-7. PubMed ID: 2936583 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Höffken G; Lode H; Prinzing C; Borner K; Koeppe P Antimicrob Agents Chemother; 1985 Mar; 27(3):375-9. PubMed ID: 3158275 [TBL] [Abstract][Full Text] [Related]
39. Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans. Brogard JM; Jehl F; Monteil H; Adloff M; Blickle JF; Levy P Antimicrob Agents Chemother; 1985 Aug; 28(2):311-4. PubMed ID: 2939796 [TBL] [Abstract][Full Text] [Related]
40. The pharmacokinetics of ciprofloxacin in patients with impaired renal function. Boelaert J; Valcke Y; Schurgers M; Daneels R; Rosseneu M; Rosseel MT; Bogaert MG J Antimicrob Chemother; 1985 Jul; 16(1):87-93. PubMed ID: 2931415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]